Literature DB >> 22123845

Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.

Steven W Lane1, Serena De Vita, Kylie A Alexander, Ruchan Karaman, Michael D Milsom, Adrienne M Dorrance, Amy Purdon, Leeann Louis, Mary L Bouxsein, David A Williams.   

Abstract

Hematopoietic stem cells (HSCs) interact with osteoblastic, stromal, and vascular components of the BM hematopoietic microenvironment (HM) that are required for the maintenance of long-term self-renewal in vivo. Osteoblasts have been reported to be a critical cell type making up the HSC niche in vivo. Rac1 GTPase has been implicated in adhesion, spreading, and differentiation of osteoblast cell lines and is critical for HSC engraftment and retention. Recent data suggest a differential role of GTPases in endosteal/osteoblastic versus perivascular niche function. However, whether Rac signaling pathways are also necessary in the cell-extrinsic control of HSC function within the HM has not been examined. In the present study, genetic and inducible models of Rac deletion were used to demonstrate that Rac depletion causes impaired proliferation and induction of apoptosis in the OP9 cell line and in primary BM stromal cells. Deletion of Rac proteins caused reduced trabecular and cortical long bone growth in vivo. Surprisingly, HSC function and maintenance of hematopoiesis in vivo was preserved despite these substantial cell-extrinsic changes. These data have implications for therapeutic strategies to target Rac signaling in HSC mobilization and in the treatment of leukemia and provide clarification to our evolving concepts of HSC-HM interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123845      PMCID: PMC3265198          DOI: 10.1182/blood-2011-07-368753

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

Authors:  F C Yang; S J Atkinson; Y Gu; J B Borneo; A W Roberts; Y Zheng; J Pennington; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling.

Authors:  Ryo Fukuyama; Takashi Fujita; Yasutaka Azuma; Akihiko Hirano; Hiromichi Nakamuta; Masao Koida; Toshihisa Komori
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

3.  Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.

Authors:  Abel Sanchez-Aguilera; Yun-Jung Lee; Cristina Lo Celso; Francesca Ferraro; Kristina Brumme; Subhanjan Mondal; Chaekyun Kim; Adrienne Dorrance; Hongbo R Luo; David T Scadden; David A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

4.  Unsuspected effects of a lung-specific Cre deleter mouse line.

Authors:  Lucie Jeannotte; Josée Aubin; Sylvie Bourque; Margot Lemieux; Séverine Montaron; Anne Provencher St-Pierre
Journal:  Genesis       Date:  2011-03       Impact factor: 2.487

5.  Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases.

Authors:  Yi Gu; Marie-Dominique Filippi; Jose A Cancelas; Jamie E Siefring; Emily P Williams; Aparna C Jasti; Chad E Harris; Andrew W Lee; Rethinasamy Prabhakar; Simon J Atkinson; David J Kwiatkowski; David A Williams
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

6.  Identification of the haematopoietic stem cell niche and control of the niche size.

Authors:  Jiwang Zhang; Chao Niu; Ling Ye; Haiyang Huang; Xi He; Wei-Gang Tong; Jason Ross; Jeff Haug; Teri Johnson; Jian Q Feng; Stephen Harris; Leanne M Wiedemann; Yuji Mishina; Linheng Li
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

7.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

8.  Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions.

Authors:  D A Williams; M Rios; C Stephens; V P Patel
Journal:  Nature       Date:  1991-08-01       Impact factor: 49.962

9.  Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.

Authors:  Scott T Avecilla; Koichi Hattori; Beate Heissig; Rafael Tejada; Fang Liao; Koji Shido; David K Jin; Sergio Dias; Fan Zhang; Travis E Hartman; Neil R Hackett; Ronald G Crystal; Larry Witte; Daniel J Hicklin; Peter Bohlen; Dan Eaton; David Lyden; Fredric de Sauvage; Shahin Rafii
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

10.  The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.

Authors:  T Papayannopoulou; C Craddock; B Nakamoto; G V Priestley; N S Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more
  13 in total

1.  Perivascular deletion of murine Rac reverses the ratio of marrow arterioles and sinusoid vessels and alters hematopoiesis in vivo.

Authors:  Marioara F Ciuculescu; Shin-Young Park; Kimberly Canty; Ronald Mathieu; Leslie E Silberstein; David A Williams
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 2.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.

Authors:  Marc H G P Raaijmakers
Journal:  Int J Hematol       Date:  2012-01-06       Impact factor: 2.490

3.  The regulation of normal and leukemic hematopoietic stem cells by niches.

Authors:  Meng-Meng Huang; Jiang Zhu
Journal:  Cancer Microenviron       Date:  2012-07-22

4.  Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.

Authors:  Phuong T Le; Kathleen A Bishop; David E Maridas; Katherine J Motyl; Daniel J Brooks; Kenichi Nagano; Roland Baron; Mary L Bouxsein; Clifford J Rosen
Journal:  Bone       Date:  2017-08-15       Impact factor: 4.398

5.  Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.

Authors:  Qiaoqiao Wan; Eunhye Cho; Hiroki Yokota; Sungsoo Na
Journal:  Biochem Biophys Res Commun       Date:  2013-03-21       Impact factor: 3.575

Review 6.  The cytoskeleton and connected elements in bone cell mechano-transduction.

Authors:  Nicole R Gould; Olivia M Torre; Jenna M Leser; Joseph P Stains
Journal:  Bone       Date:  2021-04-21       Impact factor: 4.626

7.  Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.

Authors:  Vanessa Scanlon; Do Yu Soung; Naga Suresh Adapala; Elise Morgan; Marc F Hansen; Hicham Drissi; Archana Sanjay
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

8.  Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.

Authors:  Jianjiao Ni; Xiaofei Zhang; Juan Li; Zhiqin Zheng; Junhua Zhang; Weixin Zhao; Liang Liu
Journal:  Cell Death Dis       Date:  2021-07-02       Impact factor: 8.469

9.  An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility.

Authors:  Riikka E Mäkitie; Petra Henning; Yaming Jiu; Anders Kämpe; Konstantin Kogan; Alice Costantini; Ville-Valtteri Välimäki; Carolina Medina-Gomez; Minna Pekkinen; Isidro B Salusky; Camilla Schalin-Jäntti; Maria K Haanpää; Fernando Rivadeneira; John H Duncan Bassett; Graham R Williams; Ulf H Lerner; Renata C Pereira; Pekka Lappalainen; Outi Mäkitie
Journal:  JBMR Plus       Date:  2021-06-07

10.  Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells.

Authors:  R Thaler; S Spitzer; H Karlic; C Berger; K Klaushofer; F Varga
Journal:  Biochem Pharmacol       Date:  2012-10-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.